SHR-1707

· Shanghai Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SHR-1707, covering 2025-07-11 to 2025-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients. [Phase 1]